ImmunityBio Stock (NASDAQ: IBRX) stock price, news, charts, stock research, profile.
Open | $6.45 |
Close | $6.40 |
Volume / Avg. | 2.16M / 6.74M |
Day Range | 6.33 - 6.58 |
52 Wk Range | 1.25 - 10.53 |
Market Cap | $4.43B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 31.38% |
Days to Cover | 9.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ImmunityBio (NASDAQ:IBRX) through any online brokerage.
Other companies in ImmunityBio’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA) and Ultragenyx Pharmaceutical (NASDAQ:RARE).
There is no analysis for ImmunityBio.
ImmunityBio has a consensus price target of $7.00.
The stock price for ImmunityBio (NASDAQ: IBRX) is $6.4 last updated Today at July 16, 2024 at 4:47 PM EDT.
There are no upcoming dividends for ImmunityBio.
ImmunityBio’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for ImmunityBio.
ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.